| AntiJen | IEDB |
---|
 | DRB1*0101 | DRB1*0401 | DRB1*1501 | DRB1*0101 | DRB1*0401 | DRB1*1501 |
ISC-PLC
| 0.709 | 0.757 | 0.609 | Â | Â | Â |
SMM-align
| 0.718 | 0.806 | 0.691 | 0.702 | 0.741 | 0.715 |
TEPITOPE
| 0.667 | 0.744 | 0.665 | 0.647 | 0.754 | 0.726 |
Chang
| 0.770 | 0.757 | 0.677 | Â | Â | Â |
SMM-regr
| 0.807 | 0.819 | 0.741 | 0.744 | 0.750 | 0.718 |
SMM-regr-alter
| 0.616 | 0.785 | 0.669 | 0.645 | 0.721 | 0.712 |
SMM-PFR
| 0.742 | 0.814 | 0.726 | 0.716 | 0.756 | 0.733 |
- The methods are; ISC-PLS [15], SMM-align, TEPITOPE, Chang [11], SMM-regr (SMM with peptide length regression correction from training data set), SMM-regr-alter (SMM with peptide length regression correction from alternative AntiJen/IEDB dataset), and SMM-PFR (The SMM-PRF method refers to the extended SMM align method including penalties for long peptides and short amino terminal peptide flanking residues). The data sets consist of peptides binding data from two sources (IEDB and AntiJen) covering three HLA-DR alleles (1*0101, 1*0401, and 1*1501). Performance value for the ISC-PLS and Chang methods, are taken from Chang et al. [11]. These values are only available for the AntiJen data set.